Table 5.

Plasma lipid status, cardiovascular risk markers, and atherogenic index in female rats treated with lead (50 mg/l) for 40 and 65 days

	Control 40 days	Lead 40 days	Control 65 days	Lead 65 days
Triglycerides (g/l)	0.88 ± 0.06	1.23 ± 0.07 b	0.95 ± 0.09	1.41 ± 0.10 a
Cholesterol (g/l)	0.52 ± 0.02	0.71 ± 0.02 c	0.55 ± 0.01	0.62 ± 0.01 b
HDL-Chol (g/l)	0.41 ± 0.01	0.40 ± 0.01	0.52 ± 0.01	0.41 ± 0.01 a
LDL-Chol (g/l)	0.05 ± 0.01	0.18 ± 0.02 c	0.09 ± 0.01	0.16 ± 0.01 b
LDL/HDL	0.10 ± 0.04	0.47 ± 0.09 c	0.16 ± 0.02	0.36 ± 0.05 c
Cholesterol/HDL	1.36 ± 0.07	1.85 ± 0.17 b	1.07 ± 0.03	1.31 ± 0.06 a
Triglycerides/HDL	2.35 ± 0.21	3.28 ± 0.33 b	1.65 ± 0.17	2.64 ± 0.41 b
AI	0.33 ± 0.06	0.84 ± 0.15 c	0.12 ± 0.02	0.51 ± 0.07 c

Values are mean±SD for groups consisted of 12-16 rats. Statistically significant differences are indicated

^aP<0.05;

^bP<0.01;

^cP<0.001 compared with control group